HomeCompareKPDCF vs MRK

KPDCF vs MRK: Dividend Comparison 2026

KPDCF yields 4.60% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KPDCF wins by $106.00M in total portfolio value
10 years
KPDCF
KPDCF
● Live price
4.60%
Share price
$1.74
Annual div
$0.08
5Y div CAGR
81.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$106.06M
Annual income
$95,523,779.19
Full KPDCF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KPDCF vs MRK

📍 KPDCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKPDCFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KPDCF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KPDCF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KPDCF
Annual income on $10K today (after 15% tax)
$390.80/yr
After 10yr DRIP, annual income (after tax)
$81,195,212.31/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KPDCF beats the other by $81,186,883.90/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KPDCF + MRK for your $10,000?

KPDCF: 50%MRK: 50%
100% MRK50/50100% KPDCF
Portfolio after 10yr
$53.06M
Annual income
$47,766,788.66/yr
Blended yield
90.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KPDCF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
1.5
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KPDCF buys
0
MRK buys
0
No recent congressional trades found for KPDCF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKPDCFMRK
Forward yield4.60%2.76%
Annual dividend / share$0.08$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR81.5%32.7%
Portfolio after 10y$106.06M$56.8K
Annual income after 10y$95,523,779.19$9,798.13
Total dividends collected$105.22M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: KPDCF vs MRK ($10,000, DRIP)

YearKPDCF PortfolioKPDCF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,534$834.48$11,206$366.19+$328.00KPDCF
2$13,975$1,632.71$12,650$502.35+$1.3KKPDCF
3$18,308$3,355.39$14,407$694.19+$3.9KKPDCF
4$27,046$7,456.62$16,585$967.82+$10.5KKPDCF
5$47,625$18,685.22$19,342$1,363.89+$28.3KKPDCF
6$106,769$55,810.45$22,913$1,947.19+$83.9KKPDCF
7$326,479$212,236.43$27,662$2,823.89+$298.8KKPDCF
8$1,450,170$1,100,837.01$34,159$4,173.35+$1.42MKPDCF
9$9,845,969$8,294,287.18$43,337$6,308.80+$9.80MKPDCF
10$106,058,966$95,523,779.19$56,776$9,798.13+$106.00MKPDCF

KPDCF vs MRK: Complete Analysis 2026

KPDCFStock

Listed on 12 December 2014, Keppel DC REIT is the first pure-play data centre REIT listed in Asia and on the Singapore Exchange (SGX-ST). Keppel DC REIT's investment strategy is to principally invest, directly or indirectly, in a diversified portfolio of income-producing real estate assets which are used primarily for data centre purposes, as well as real estate related assets. As at 31 December 2020, its portfolio comprises 19 data centres strategically located in key data centre hubs. With an aggregate lettable area of approximately 2,089,085 sq ft, the portfolio spans 12 cities in eight countries across Asia Pacific and Europe. Keppel Telecommunications & Transportation Ltd (Keppel T&T), the Sponsor of the REIT, has also granted Rights of First Refusal (ROFR) to the REIT for future acquisition opportunities of its data centre assets. The REIT is managed by Keppel DC REIT Management Pte. Ltd.. Keppel Capital Holdings Pte. Ltd. (Keppel Capital) has a 50% interest in the Manager, with the remaining interest held by Keppel T&T. Keppel Capital is a premier asset manager in Asia with assets under management comprising real estate, infrastructure and data centre properties in key global markets. The Manager's key objectives are to provide the REIT's Unitholders with regular and stable distributions, as well as achieve long-term growth while maintaining an optimal capital structure.

Full KPDCF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KPDCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KPDCF vs SCHDKPDCF vs JEPIKPDCF vs OKPDCF vs KOKPDCF vs MAINKPDCF vs JNJKPDCF vs ABBVKPDCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.